THAT — Thalia Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.10m
- £9.59m
- £0.01m
SRI Research Update
Brief: N4 Pharma Says Unit Applied To U.S. FDA To Obtain Orphan Drug Designation For ECP105
Nanogenics Update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
New Corporate Presentation
Placing and Subscription to raise £630,000
Holding(s) in Company
Posting of Annual Report & Notice of AGM
N4 Pharma Webinar on SRI Collaboration
Brief: N4 Pharma Announces Collaboration Agreement With SRI International
Collaboration Agreement with SRI International Inc
Final Results
Oral Delivery Update
Holding(s) in Company
Holding(s) in Company
in-vitro siRNA update
Holding(s) in Company